Advertisement
News
Advertisement

CeQur’s insulin delivery device approved in Europe

Tue, 11/27/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

CeQur Corp., which has its U.S. headquarters in Marlborough, has received CE Mark approval for its lead product, which provides three days of consistent delivery of insulin to people with type 2 diabetes.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading